Cargando…
Clinical and Preclinical Evidence for M(1) Muscarinic Acetylcholine Receptor Potentiation as a Therapeutic Approach for Rett Syndrome
Rett syndrome (RTT) is a neurodevelopmental disorder that is characterized by developmental regression, loss of communicative ability, stereotyped hand wringing, cognitive impairment, and central apneas, among many other symptoms. RTT is caused by loss-of-function mutations in a methyl-reader known...
Autores principales: | Smith, Mackenzie, Arthur, Bright, Cikowski, Jakub, Holt, Calista, Gonzalez, Sonia, Fisher, Nicole M., Vermudez, Sheryl Anne D., Lindsley, Craig W., Niswender, Colleen M., Gogliotti, Rocco G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587166/ https://www.ncbi.nlm.nih.gov/pubmed/35670902 http://dx.doi.org/10.1007/s13311-022-01254-3 |
Ejemplares similares
-
Optimized Administration of the M(4) PAM
VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations
in Mecp2(+/–) Mice
por: Cikowski, Jakub, et al.
Publicado: (2022) -
Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model
por: Vermudez, Sheryl Anne D., et al.
Publicado: (2021) -
Crystal structure of the M(5) muscarinic acetylcholine receptor
por: Vuckovic, Ziva, et al.
Publicado: (2019) -
Allosteric Modulation of Muscarinic Acetylcholine Receptors
por: Gregory, Karen J, et al.
Publicado: (2007) -
Probing the binding site of novel selective positive allosteric modulators at the M(1) muscarinic acetylcholine receptor
por: Khajehali, Elham, et al.
Publicado: (2018)